Close

Endo Int'l (ENDP) Announces Statistically Significant Data from Xiaflex Phase 2 in Dupuytren's Disease Nodules

September 30, 2016 7:31 AM EDT Send to a Friend
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (Nasdaq: ENDP), announced new data to be presented evaluating the safety ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login